| Drug use beyond the licence in palliative care: A systematic review and narrative synthesis V Hagemann, C Bausewein, C Remi Palliative medicine 33 (6), 650-662, 2019 | 34 | 2019 |
| Off-label-prescriptions in daily clinical practice–a cross-sectional national survey of palliative medicine physicians V Hagemann, C Bausewein, C Rémi Progress in Palliative Care 27 (4), 154-159, 2019 | 14 | 2019 |
| Off-label drugs in palliative care: a Group Delphi treatment recommendation process C Remi, K Weingärtner, V Hagemann, C Bausewein, F Hodiamont BMJ Supportive & Palliative Care 11 (2), 180-187, 2021 | 10 | 2021 |
| Off-label use in adult palliative care–more common than expected. A retrospective chart review V Hagemann, C Bausewein, C Remi European Journal of Hospital Pharmacy 29 (6), 329-335, 2022 | 2 | 2022 |
| Off-label use in Palliative Care–more common than expected. A retrospective chart review V Hagemann, C Bausewein, C Rémi medRxiv, 2021.01. 17.21249962, 2021 | 1 | 2021 |
| Anwendungspraxis von Arzneimitteln außerhalb der Zulassung in deutschen Einrichtungen der spezialisierten palliativmedizinischen Versorgung VC Hagemann lmu, 2022 | | 2022 |
| Guide for recommendations on specific drug-related off-label treatment in palliative care: A Group Delphi process C Remi, K Weingärtner, V Hagemann, C Bausewein, F Hodiamont | | 2019 |
| Off-Label-Use im klinischen Alltag–eine Umfrage unter Palliativmedizinern in Deutschland V Hagemann, C Bausewein, C Rémi Zeitschrift für Palliativmedizin 19 (05), P49, 2018 | | 2018 |
Constanze Remi在 med.uni-muenchen.de 的电子邮件经过验证
Constanze Remi在 med.uni-muenchen.de 的电子邮件经过验证